Celldex Therapeutics, Inc. CLDX
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T14:57:30.750Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T14:56:42.811782692Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T14:57:28.936759+00:00
Celldex Therapeutics, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | 25.85 | 160.3% | 16.4% | |||
| 30Δ | 35.75 | 191.4% | 26.2% | 27.52 | 99.6% | 9.6% |
| 35Δ | 33.89 | 179.0% | 20.6% | 28.22 | 95.9% | 8.0% |
| 40Δ | 28.72 | 108.7% | 7.7% | |||
| 45Δ | 30.92 | 139.9% | 11.4% | 29.24 | 111.8% | 7.0% |
| 50Δ | 30.28 | 160.2% | 11.1% | 29.78 | 102.1% | 5.5% |
| 55Δ | 30.18 | 94.0% | 4.5% | |||
| 60Δ | 28.67 | 127.0% | 6.4% | 30.49 | 87.0% | 3.8% |
| 65Δ | 28.10 | 119.9% | 5.3% | 30.79 | 80.0% | 3.2% |
| 70Δ | 27.53 | 112.8% | 4.2% | 31.10 | 72.9% | 2.5% |
| 75Δ | 26.96 | 105.7% | 3.2% | 31.40 | 65.9% | 1.8% |
| 80Δ | 26.39 | 98.6% | 2.1% | 31.71 | 58.9% | 1.1% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 25.85
- IV
- 160.3%
- B/E move
- 16.4%
30Δ
- Pseudo strike
- 35.75
- IV
- 191.4%
- B/E move
- 26.2%
- Pseudo strike
- 27.52
- IV
- 99.6%
- B/E move
- 9.6%
35Δ
- Pseudo strike
- 33.89
- IV
- 179.0%
- B/E move
- 20.6%
- Pseudo strike
- 28.22
- IV
- 95.9%
- B/E move
- 8.0%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 28.72
- IV
- 108.7%
- B/E move
- 7.7%
45Δ
- Pseudo strike
- 30.92
- IV
- 139.9%
- B/E move
- 11.4%
- Pseudo strike
- 29.24
- IV
- 111.8%
- B/E move
- 7.0%
50Δ
- Pseudo strike
- 30.28
- IV
- 160.2%
- B/E move
- 11.1%
- Pseudo strike
- 29.78
- IV
- 102.1%
- B/E move
- 5.5%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 30.18
- IV
- 94.0%
- B/E move
- 4.5%
60Δ
- Pseudo strike
- 28.67
- IV
- 127.0%
- B/E move
- 6.4%
- Pseudo strike
- 30.49
- IV
- 87.0%
- B/E move
- 3.8%
65Δ
- Pseudo strike
- 28.10
- IV
- 119.9%
- B/E move
- 5.3%
- Pseudo strike
- 30.79
- IV
- 80.0%
- B/E move
- 3.2%
70Δ
- Pseudo strike
- 27.53
- IV
- 112.8%
- B/E move
- 4.2%
- Pseudo strike
- 31.10
- IV
- 72.9%
- B/E move
- 2.5%
75Δ
- Pseudo strike
- 26.96
- IV
- 105.7%
- B/E move
- 3.2%
- Pseudo strike
- 31.40
- IV
- 65.9%
- B/E move
- 1.8%
80Δ
- Pseudo strike
- 26.39
- IV
- 98.6%
- B/E move
- 2.1%
- Pseudo strike
- 31.71
- IV
- 58.9%
- B/E move
- 1.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 62.28% | |
| 64.66% | |
| 59.10% | |
| 55.30% | |
| 57.39% | |
| 55.47% | |
| 59.05% | |
| 50.83% | |
| 50.32% | |
| 56.15% |
Biotechnology
CLYM
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. The company is headquartered in Wilmington, Delaware.
More →CMPX
Description unavailable
More →CNTB
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe…
More →COGT
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge,…
More →CORT
Description unavailable
More →COYA
Description unavailable
More →